TWST

Twist Bioscience Corporation Common Stock

127.22

USD

+0.37

+0.29%

Sep 11, 15:59 UTC -4

Closed

Pre-Market

126.83

-0.39

-0.31%

Twist Bioscience Corporation Common Stock Profile

About

Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California.

Info & Links

CEO

Emily M. Leproust

Headquarters

681 GATEWAY BLVD.
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

979

Twist Bioscience Corporation Common Stock Statistics

Valuation Measures

Market Capitalization²

8.41B

Enterprise Value

8.31B

Enterprise Value/EBITDA(ttm)

-69.46

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

18.48

Price to Book(mrq)

17.90

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

51.94%

Operating Margin(ttm)

-30.34%

Profit Margin(ttm)

-31.55%

Return on Equity(ttm)

-28.64%

Return on Invested Capital(ttm)

-29.01%

Return on Assets(ttm)

-19.94%

Income Statement

Revenue(ttm)

431.80M

Revenue Per Share(ttm)

6.89

Gross Profit(ttm)

224.38M

EBITDA(ttm)³

-119.59M

Net Income Available to Common(ttm)

-136.72M

Diluted EPS(ttm)

-2.22

Share Statistics

Beta (5Y Monthly)

2.22

52-Week Change

402.65%

S&P 500 52-Week Change

18.73%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

62.71M

Dividend Yield

0.00%

Float⁴

60.78M

% Held by Insiders

3.08%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

166.84M

Total Cash Per Share(mrq)

2.66

Total Debt(mrq)

15.00M

Total Debt/Equity(mrq)

3.37%

Current Ratio(mrq)

2.67%

Quick Ratio(mrq)

2.38%

Book Value Per Share(mrq)

7.11

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.66

Free Cash Flow(ytd)

-68.88M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.